A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults

NCT07515339 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study is no longer required.

Conditions

Chronic Kidney Disease

Interventions

DRUG: Nurandociguat
DRUG: Rosuvastatin
DRUG: Dabigatran etexilate

Sponsor

Bayer